Candidate gene
Marker
| associated with a better survival in lung adenocarcinoma and had an independent prognostic value and may thus be used in the evaluation of patient prognosis |
|
marker for the early carcinogenetic process, is commonly expressed in precursor lesions of pancreatic ductal adenocarcinomas |
|
the expression of CLDN7 and the loss of CLDN18 may be independent indicators of a poor prognosis in patients with gastric cancer |
|
is likely a promising surrogate marker to separate gastric-type carcinoma (GAS) from other types of endocervical gastric-type carcinoma, including clear cell carcinoma |
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | digestive | stomach | |
(CLDN18.2) is a promising target in Gastric cancer (GC) therapy |
| |